SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
SpringWorks Therapeutics, Inc. (SWTX) , 前瞻盈利收益率 3.67%.
本页证实的标准:
- VALUE (90/100, 通过) — 分析师目标价暗示上行空间 (+33%).
- 前瞻市盈率 27.3
- 分析师共识目标价 $62.50 (+33% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 57/100 其中 4/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
90/100
Price-to-Earnings & upside
Proven by this page
✓
健康
100/100
Debt-to-Equity & liquidity
→ Health
估值概览 — SWTX
估值倍数
P/E (TTM)0.0
前瞻 P/E27.3
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率18.18
EV/EBITDA0.0
每股数据
EPS (TTM)$-3.48
前瞻 EPS（预估）$1.72
每股账面价值$0.00
每股营收$2.58
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield3.67%
股息收益率0.00%
分析师目标价$62.50 (+33%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2017 |
$-0.11 |
$0.00 |
$-4.64M |
- |
| 2018 |
$-0.80 |
$0.00 |
$-17.81M |
- |
| 2019 |
$-1.27 |
$0.00 |
$-54.76M |
- |
| 2020 |
$-1.02 |
$35M |
$-44.24M |
-126.4% |
| 2021 |
$-3.57 |
$0.00 |
$-173.21M |
- |
| 2022 |
$-5.14 |
$6.15M |
$-274.16M |
-4460.1% |
| 2023 |
$-5.15 |
$5.45M |
$-325.1M |
-5968.5% |
| 2024 |
$-3.48 |
$191.59M |
$-258.13M |
-134.7% |
